AGE-SPECIFIC REGULATION OF CLOTTING FACTOR-IX GENE-EXPRESSION IN NORMAL AND TRANSGENIC MICE

被引:19
作者
BOLAND, EJ [1 ]
LIU, YC [1 ]
WALTER, CA [1 ]
HERBERT, DC [1 ]
WEAKER, FJ [1 ]
ODOM, MW [1 ]
JAGADEESWARAN, P [1 ]
机构
[1] UNIV TEXAS, HLTH SCI CTR, DEPT CELLULAR & STRUCT BIOL, SAN ANTONIO, TX 78284 USA
关键词
D O I
10.1182/blood.V86.6.2198.bloodjournal8662198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor IX (FIX), a circulating serine protease that serves as an essential component of the blood coagulation pathway, has been shown to increase with age in humans. We show here that murine FIX mRNA and activity levels also increase with age. Furthermore, one form of hemophilia B, hemophilia B Leyden, which is caused by mutations within the promoter region of the FIX gene, has a distinct age-dependent phenotype. To determine the source of the age-related increases in FIX gene expression, we have analyzed the regulation of the normal FIX gene promoter and FIX Leyden gene promoter with the +13 mutation during aging by generating transgenic mice that contain the -189 to +21 bp promoter segment ligated to a chloramphenicol acetyltransferase reporter gene. We have established that the normal FIX promoter and the Leyden promoter transgenes are expressed in a tissue-specific manner in vivo, The normal FIX promoter transgene does not show any differences in the pattern of expression with age or sex of the organism, whereas the Leyden promoter transgene showed age-dependent male-specific expression. This is the first demonstration of the FIX Leyden phenotype in a transgenic mouse model. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:2198 / 2205
页数:8
相关论文
共 33 条
[1]  
[Anonymous], 1986, MANIPULATING MOUSE E
[2]   THE GENE STRUCTURE OF HUMAN ANTI-HEMOPHILIC FACTOR-IX [J].
ANSON, DS ;
CHOO, KH ;
REES, DJG ;
GIANNELLI, F ;
GOULD, K ;
HUDDLESTON, JA ;
BROWNLEE, GG .
EMBO JOURNAL, 1984, 3 (05) :1053-1060
[3]  
BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   THE PROPHYLACTIC TREATMENT OF HEMOPHILIA-B LEYDEN WITH ANABOLIC-STEROIDS [J].
BRIET, E ;
WIJNANDS, MC ;
VELTKAMP, JJ .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (02) :225-226
[6]   HEMOPHILIA-B LEYDEN - A SEX-LINKED HEREDITARY DISORDER THAT IMPROVES AFTER PUBERTY [J].
BRIET, E ;
BERTINA, RM ;
VANTILBURG, NH ;
VELTKAMP, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (13) :788-790
[7]  
CHEN D, 1992, J BIOL CHEM, V267, P23502
[8]   DISRUPTION OF A C/EBP BINDING-SITE IN THE FACTOR-IX PROMOTER IS ASSOCIATED WITH HEMOPHILIA-B [J].
CROSSLEY, M ;
BROWNLEE, GG .
NATURE, 1990, 345 (6274) :444-446
[9]   RECOVERY FROM HEMOPHILIA-B LEYDEN - AN ANDROGEN-RESPONSIVE ELEMENT IN THE FACTOR-IX PROMOTER [J].
CROSSLEY, M ;
LUDWIG, M ;
STOWELL, KM ;
DEVOS, P ;
OLEK, K ;
BROWNLEE, GG .
SCIENCE, 1992, 257 (5068) :377-379
[10]   VALUE OF AGE-MATCHED AND SEX-MATCHED CONTROLS FOR COAGULATION STUDIES [J].
DODDS, WJ ;
MOYNIHAN, AC ;
BENSON, RE ;
HALL, CA .
BRITISH JOURNAL OF HAEMATOLOGY, 1975, 29 (02) :305-317